United Therapeutics (UTHR) Income After Tax (2009 - 2026)
United Therapeutics (UTHR) posted Income After Tax of $333 million for Q2 2026, up 7.6% from $309.5 million a year earlier and up 21.1% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Income After Tax (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income After Tax at United Therapeutics was $1.31 billion, up 5.5% year-over-year; for FY2025, it was $1.33 billion, up 11.7% from FY2024.
- Annual Income After Tax has increased for four consecutive years, with a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
- In prior years, United Therapeutics' Income After Tax was $1.2 billion in FY2024 (+21.4%), $984.8 million in FY2023 (+35.4%), $727.3 million in FY2022 (+52.9%) and $475.8 million in FY2021 (-7.6%).
- Quarterly Income After Tax has run from a low of $112.2 million in Q4 2021 to a high of $364.3 million in Q4 2025 over five years.
- On a year-over-year basis, Income After Tax increased in seven of the last eight quarters, with growth averaging 11.8%.
- The strongest year-over-year quarter for Income After Tax in the past five years was Q1 2022, with growth of 747.7%; the weakest was Q2 2022, with a decline of 32.8%.
- According to Business Quant data, Income After Tax for the three prior quarters was $274.9 million (Q1 2026), $364.3 million (Q4 2025) and $338.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | United Therapeutics | 24.95 Bn | 15.14 Bn | 733.40 Mn | 258.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 258.60 Mn |
| Jun 30, 2026 | 333.00 Mn |
| Mar 31, 2026 | 274.90 Mn |
| Dec 31, 2025 | 364.30 Mn |
| Sep 30, 2025 | 338.70 Mn |
| Jun 30, 2025 | 309.50 Mn |
| Mar 31, 2025 | 322.20 Mn |
| Dec 31, 2024 | 301.30 Mn |
| Sep 30, 2024 | 309.10 Mn |
| Jun 30, 2024 | 278.10 Mn |
| Mar 31, 2024 | 306.60 Mn |
| Dec 31, 2023 | 217.10 Mn |
| Sep 30, 2023 | 267.60 Mn |
| Jun 30, 2023 | 259.20 Mn |
| Mar 31, 2023 | 240.90 Mn |
| Dec 31, 2022 | 132.10 Mn |
| Sep 30, 2022 | 239.30 Mn |
| Jun 30, 2022 | 116.00 Mn |
| Mar 31, 2022 | 239.90 Mn |
| Dec 31, 2021 | 112.20 Mn |
API Access
United Therapeutics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();